Natural products in cancer chemotherapy: past, present and future
Top Cited Papers
- 1 February 2002
- journal article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 2 (2), 143-148
- https://doi.org/10.1038/nrc723
Abstract
Natural products have been the mainstay of cancer chemotherapy for the past 30 years. However, the quickening pace of (aberrant) gene identification, and the new technologies of combinatorial chemistry and high-throughput screening, should provide access to a wide range of new, totally synthetic drugs. Will these new approaches sound the death knell for therapies based on natural products? In reality, natural products are likely to provide many of the lead structures, and these will be used as templates for the construction of novel compounds with enhanced biological properties.Keywords
This publication has 45 references indexed in Scilit:
- Modifications in the upper or Velbenamine Part of the Vinca Alkaloids have Major Implications for Tubulin Interacting ActivitiesCurrent Pharmaceutical Design, 2001
- Taxol, a molecule for all seasonsChemical Communications, 2001
- Differential activity of topotecan, irinotecan and SN-38 in fresh human tumour cells but not in cell linesEuropean Journal Of Cancer, 2000
- The influence of natural products upon drug discovery (Antiquity to late 1999)Natural Product Reports, 2000
- Etoposide: four decades of development of a topoisomerase II inhibitorEuropean Journal Of Cancer, 1998
- The use of Taxol as a trademarkNature, 1995
- DNA Topoisomerases: Essential Enzymes and Lethal TargetsAnnual Review of Pharmacology and Toxicology, 1994
- Role of Plants in the National Cancer Institute Drug Discovery and Development ProgramPublished by American Chemical Society (ACS) ,1993
- Relationships between the structure of taxol analogs and their antimitotic activityJournal of Medicinal Chemistry, 1991
- Promotion of microtubule assembly in vitro by taxolNature, 1979